SAN ANTONIO--(BUSINESS WIRE)--Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, announced today the pricing of the private offering by its wholly-owned subsidiaries, Kinetic Concepts, Inc. (“KCI”) and KCI USA, Inc. (“KCI USA” and, together with KCI, the “Issuers”), of $400 million in aggregate principal amount of 7.875% first lien senior secured notes due 2021 (the “Notes”).
